Elizabeth E. Eynon

3.5k total citations
42 papers, 2.6k citations indexed

About

Elizabeth E. Eynon is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Elizabeth E. Eynon has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Elizabeth E. Eynon's work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (7 papers). Elizabeth E. Eynon is often cited by papers focused on Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (7 papers). Elizabeth E. Eynon collaborates with scholars based in United States, Switzerland and Netherlands. Elizabeth E. Eynon's co-authors include David C. Parker, Richard A. Flavell, Markus G. Manz, Anthony Rongvaux, Hitoshi Takizawa, Tim Willinger, Till Strowig, Richard A. Flavell, E. Allison Green and George D. Yancopoulos and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Elizabeth E. Eynon

42 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Elizabeth E. Eynon 1.7k 624 499 417 302 42 2.6k
Raymond J. Steptoe 2.8k 1.7× 659 1.1× 423 0.8× 547 1.3× 132 0.4× 90 3.8k
Hilary S. Warren 1.9k 1.2× 506 0.8× 220 0.4× 380 0.9× 171 0.6× 66 2.7k
Denis Hudrisier 2.3k 1.4× 530 0.8× 198 0.4× 349 0.8× 194 0.6× 54 2.8k
S Hudak 1.9k 1.1× 593 1.0× 270 0.5× 607 1.5× 272 0.9× 33 3.2k
Miren L. Baroja 1.2k 0.7× 859 1.4× 209 0.4× 437 1.0× 97 0.3× 45 2.4k
Barbara Lisowska‐Grospierre 2.4k 1.5× 472 0.8× 420 0.8× 394 0.9× 226 0.7× 42 3.0k
Elissa K. Deenick 2.7k 1.6× 498 0.8× 253 0.5× 562 1.3× 138 0.5× 39 3.4k
Tim Willinger 1.6k 0.9× 710 1.1× 311 0.6× 519 1.2× 266 0.9× 27 2.6k
Suzanne B. Hartley 2.9k 1.7× 633 1.0× 307 0.6× 349 0.8× 141 0.5× 14 3.5k
Micah J. Benson 1.9k 1.1× 579 0.9× 172 0.3× 450 1.1× 140 0.5× 17 2.7k

Countries citing papers authored by Elizabeth E. Eynon

Since Specialization
Citations

This map shows the geographic impact of Elizabeth E. Eynon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. Eynon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. Eynon more than expected).

Fields of papers citing papers by Elizabeth E. Eynon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth E. Eynon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. Eynon. The network helps show where Elizabeth E. Eynon may publish in the future.

Co-authorship network of co-authors of Elizabeth E. Eynon

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth E. Eynon. A scholar is included among the top collaborators of Elizabeth E. Eynon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth E. Eynon. Elizabeth E. Eynon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Rituparna, Till Strowig, Rakesh Verma, et al.. (2016). Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. Nature Medicine. 22(11). 1351–1357. 116 indexed citations
2.
Li, Wen, E. Allison Green, Thomas Stratmann, et al.. (2011). In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL‐1 and IL‐18. European Journal of Immunology. 41(5). 1344–1351. 12 indexed citations
3.
Lee, Won‐Woo, Seong Wook Kang, Jihoon Choi, et al.. (2010). Regulating human Th17 cells via differential expression of IL-1 receptor (34.7). The Journal of Immunology. 184(Supplement_1). 34.7–34.7. 4 indexed citations
4.
Hawiger, Daniel, Yisong Y. Wan, Elizabeth E. Eynon, & Richard A. Flavell. (2010). The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell–mediated peripheral T cell unresponsiveness. Nature Immunology. 11(10). 962–968. 48 indexed citations
5.
Song, Jeongmin, Tim Willinger, Anthony Rongvaux, et al.. (2010). A Mouse Model for the Human Pathogen Salmonella Typhi. Cell Host & Microbe. 8(4). 369–376. 139 indexed citations
6.
Lee, Won‐Woo, Seong Wook Kang, Jihoon Choi, et al.. (2009). Regulating human Th17 cells via differential expression of IL-1 receptor. Blood. 115(3). 530–540. 117 indexed citations
7.
Laouar, Yasmina, et al.. (2006). IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. International Immunology. 19(1). 1–10. 67 indexed citations
8.
Dong, Chen, Shomyseh Sanjabi, & Elizabeth E. Eynon. (2005). Gene Regulation and Function: It's Rocking Science. Immunity. 23(6). 557–560. 1 indexed citations
9.
Eynon, Elizabeth E., Lauren A. Zenewicz, & Richard A. Flavell. (2005). Sugar-Coated Regulation of T Cells. Cell. 122(1). 2–4. 5 indexed citations
10.
Eynon, Elizabeth E., Ferenc Livák, Keisuke Kuida, David G. Schatz, & Richard A. Flavell. (1999). Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.. PubMed. 162(3). 1448–59. 17 indexed citations
11.
Eynon, Elizabeth E., et al.. (1999). A Secreted Form of the Major Histocompatibility Complex Class II-associated Invariant Chain Inhibiting T Cell Activation. Journal of Biological Chemistry. 274(37). 26266–26271. 7 indexed citations
12.
Eynon, Elizabeth E., Richard A. Flavell, & Robert A. Frost. (1999). Walking through the forest of transgenic models of human disease. Immunological Reviews. 169(1). 5–10. 14 indexed citations
13.
Green, E. Allison, Elizabeth E. Eynon, & Richard A. Flavell. (1998). Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens. Immunity. 9(5). 733–743. 176 indexed citations
14.
Eynon, Elizabeth E., Keisuke Kuida, & Richard A. Flavell. (1996). Disruption of Cytokine Signaling in Lymphoid Development: Unique Contributions of the Common Cytokine Gamma Chain and the Jak3 Kinase. Journal of Interferon & Cytokine Research. 16(9). 677–684. 12 indexed citations
15.
Eynon, Elizabeth E., et al.. (1995). Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B. International Immunology. 7(7). 1065–1077. 26 indexed citations
16.
Izon, David J., Lori Jones, Elizabeth E. Eynon, & Ada M. Kruisbeek. (1994). A molecule expressed on accessory cells, activated T cells, and thymic epithelium is a marker and promoter of T cell activation.. The Journal of Immunology. 153(7). 2939–2950. 11 indexed citations
17.
Eynon, Elizabeth E. & David C. Parker. (1992). Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.. The Journal of Experimental Medicine. 175(1). 131–138. 371 indexed citations
18.
Awdeh, Z, et al.. (1992). Predictability of alloreactivity among unrelated individuals. Tissue Antigens. 39(2). 51–57. 8 indexed citations
19.
Kruskall, Margot S., Elizabeth E. Eynon, Zuheir L. Awdeh, Chester A. Alper, & E.J. Yunis. (1987). Identification of HLA-B44 subtypes associated with extended MHC haplotypes. Immunogenetics. 26(4-5). 216–219. 21 indexed citations
20.
Eynon, Elizabeth E., et al.. (1986). Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns. Human Immunology. 16(4). 356–363. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026